Literature DB >> 6653579

The systemic and coronary haemodynamic effects of felodipine in patients with coronary heart disease.

A C Tweddel, G Johnsson, T H Pringle, R G Murray, I Hutton.   

Abstract

The cardiovascular effects of felodipine, a new arteriolar vasodilator, were studied in 22 patients with coronary heart disease. There were significant falls in blood pressure and systemic vascular resistance of 16 and 38% respectively (P = 0.001), thus affecting after-load. Cardiac index and stroke index increased by 35 and 12% respectively. There was reflex tachycardia--from 75 +/- 3 to 85 +/- 3 b.p.m. (P = 0.005). Coronary sinus blood flow increased from 134 +/- 9 to 191 +/- 17 ml/min (P less than 0.005) and myocardial arterio-venous oxygen difference narrowed from 12.1 +/- 0.5 to 9.0 +/- 0.4 vols% (P less than 0.001) indicating less oxygen usage. With the heart rate held constant by atrial pacing, cardiac index and stroke index increased by 30 and 26% (P less than 0.001), whilst systolic blood pressure and systemic vascular resistance fell by 20 and 29% (P less than 0.001). This would suggest that the improved haemodynamics were largely secondary to after-load reduction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6653579     DOI: 10.1093/oxfordjournals.eurheartj.a061381

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  15 in total

1.  The effects of felodipine in angina pectoris.

Authors:  A R Lorimer; P MacFarlane; S Pringle; M P Barbour; Y Fox; T D Lawrie
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Acute haemodynamic effects of felodipine in congestive heart failure.

Authors:  H Emanuelsson; A Hjalmarson; S Holmberg; F Waagstein
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Haemodynamic effects of single-dose felodipine in normal man.

Authors:  E Agner; M Rehling; J Trap-Jensen
Journal:  Drugs       Date:  1985       Impact factor: 9.546

4.  Electrophysiological effects of felodipine.

Authors:  M Been; P W Macfarlane; W S Hillis
Journal:  Drugs       Date:  1985       Impact factor: 9.546

Review 5.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

Review 6.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

7.  The haemodynamic effects of long term felodipine therapy in previously untreated essential hypertension.

Authors:  S Capewell; C G Wathen; W J Hannan; A L Muir
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

8.  Felodipine in ischaemic heart disease.

Authors:  J V Sheridan; P Thomas; D J Sheridan
Journal:  Drugs       Date:  1987       Impact factor: 9.546

9.  Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure.

Authors:  A D Timmis; P Smyth; J F Kenny; S Campbell; D E Jewitt
Journal:  Br Heart J       Date:  1984-09

10.  Hemodynamic effects of felodipine in congestive heart failure.

Authors:  G Binetti; S Pancaldi; N Giovanelli; S Negroni; R M Ferretti; A Branzi; S Specchia; B Magnani
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.